| Subject: | FDA Seeks Comments on Interim Final Rule about Informed Consent |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Mon, 10 Jul 2006 - 12:00 am |
| The FDA has issued an interim final rule to amend its regulations and establish a new exception from the general requirements for informed consent. The interim rule permits the use of investigational in vitro diagnostic devices to identify chemical, biological, radiological, or nuclear agents without informed consent in certain circumstances.
The FDA has initiated this interim final rule because of concerns that during a potential terrorist event or other potential public health emergency,... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
REFERENCE:
Policies / Forms / Additional Resources:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. The strength of StayAlert! rests in its ability to allow healthcare organizations to streamline their businesses using the Internet as a foundation architecture. StayAlert! provides cost containment and reduction through elimination of unnecessary overhead, and work caused by errors or poor access to information. |
|
